Association between angiotensin-1 converting enzyme gene polymorphism and the metabolic syndrome in a Mexican population

Experimental and Molecular Medicine

Volumn 39, Issue 3, 2007, Pages 327-334

  Alvarez Aguilar, Cleto ^a   Enríquez Ramírez, Maria Lucia ^a   Figueroa Nuñez, Benigno ^a   Gómez García, Anel ^a,b   Rodríguez Ayala, Ernesto ^a   Morán Moguel, Cristina ^b   Farías Rodríguez, Victor Manuel ^c   Mino León, Dolores ^b   López Meza, Joel Edmundo ^c  

^a Instituto Mexicano de Seguro Social   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

Author keywords

Metabolic syndrome X; Obesity; Peptidyldipeptidase A; Polymorphism, genetic; Renin angiotensin system; Risk factors

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MEXICO; POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 34447125039     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2007.36     Document Type: Article

References (49)

1. Alsaeid M, Moussa MAA, Haider MZ, Refai TM, Abdella N, Al-Sheikh N, Gomez JE. Angiotensin converting enzyme gene polymorphism and the lipid profiles in Kuwaiti children with type 1 diabetes. Pediatr Diabetes 2004;5:87-94
2. Asamoah A, Yanamandra K, Thurmon TF, Richter R, Green R, Lakin T, Martin C. A deletion in the angiotensin converting enzyme (ACE) gene is common among African Americans with essential hypertension. Clin Chem Acta 1996;254:41-6
3. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, Ogunlesi AO. Sagnella GA. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens 1994;12:955-7
4. Boucher R, Rojo-Ortega JM, Genest J. Description of renin-angiotensin system and methods of measurement. In Hypertension (Genest T, Koiw E, Kuchel O, eds), Hypertension, 1977, 140-154, McGraw-Hill, New York
5. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G. Plasma levels and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994;90:669-76
6. Caulfield M, Lavender P, Farral M, Munroe P, Lawson M, Turner P, Clark AJ. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-32
7. Chiu KC, McCarty JE. The insertion allele at the angiotensin I-converting enzyme gene locus is associated with insulin resistance. Metabolism 1997;46:395-9
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72
9. Costa LA, Canani LH, Maia AL, Gross JL. The ACE insertion/ deletion polymorphism is not associated with the metabolic syndrome (WHO definition) in Brazilian type 2 diabetic patients. Diabetes Care 2002;25:2365-6
10. Dandona P, Aljada A, Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin:a new paradigm. Diabetologia 2002;45:924-30
11. Diagnosis and Classification of Diabetes Mellitus. American Diabetes Association. Diabetes Care 2004;27(Suppl 1):S5-10
12. Doelle GC. The clinical picture of metabolic syndrome: an update on this complex of conditions and risk factors. Postgrad Med 2004;116:30-8
13. Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005;45:356-62
14. Erdos GE, Skidgel AR. The angiotensin I-converting enzyme. Lab Invest 1987;56:345-8
15. Ergen HA, Hatemi H, Agachan B, Camlica H, Isbir T. Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Exp Mol Med 2004;36:345-50
16. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). JAMA 2001;285:2486-97
17. Feng Y, Niu T, Xu X, Chen C, Li Q, Qian R, Wang G, Xu X. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 2002;51:1986-8
18. Festa A, D'Agostino R Jr, Tracy RP , Haffner SM. Elevated levels on acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: The Insulin Resistance Atherosclerosis Study. Diabetes 2002;51:1131-7
19. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 2002;16:356-9
20. Giacchetti G, Faloia E, Mariniello B, Sardu C, Gatti C, Camilloni MA, Guerrieri M, Montero F. Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 2002;15:381-8
21. Gilbert RE, Krum H, Wilkinson-Berka J, Kelly DJ. The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations. Diabet Med 2003;20:607-21
22. Gorodezky C, Alaez C, Vazquez-Garcia MN, de la Rosa G, Infante E, Balladares S, Toribio R, Perez-Luque E, Munoz L. The genetic structure of Mexican Mestizos of different locations: tracking back their origins through MHC genes, blood group systems, and microsatellites. Hum Immunol 2001;62:979-91
23. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on cientific issues related to management. Circulation 2004;109:551-6
24. Harp JB, Henry SA, DiGirolamo M. Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults. Obes Res 2002;10:985-90
25. Harrap SB. Cardiovascular disease and genetics of the renin-angiotensin system. Heart 1996;76(Suppl 3):13-7
26. Ilanne-Parikka P, Eriksson JG, Lindstrom J, Hamalainen H, Keinanen-Kiukaanniemi S, Lalkso M, Louheranta A, Mannelin M, Rastas M, Salminen V, Aunola S, Sundvall J, Valle T, Lahtela J, Uusitupa M, Tuomilehto J. Prevalence of metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study Cohort. Diabetes Care 2004;27:2135-40
27. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9
28. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin converting enzyme gene is a risk factor to left ventricular hypertrophy. Circulation 1994;90:2622-8
29. Keidar S, Kaplan M, Shapira C, Brook JG, Aviram M. Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Atherosclerosis 1994;107:71-84
30. Keidar S, Kaplan M, Aviram M. Angiotensin II-modified LDL is taken up by macrophages via scavenger receptor, leading to cellular cholesterol accumulation. Arterioescler Thromb Vasc Biol 1996;16:97-105
31. Lee YJ, Tsai JCR. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002;25:1002-8
32. Lwanga SK. Lemeshow S. Tamano de muestra para calculo de una proporción con precisión absoluta específica. In Determinación del Tamaño de las Muestras en los Estudios sanitarios,1991, 12-26, World Health Organization, Geneva
33. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Disselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 1997;99:1585-95
34. Masuzaki H, Yamamoto H, Kenyon CJ, Elsquist JK, Morton NM, Peterson JM, Shinyama H, Sharp MGF, Fleming S, Mullins JJ, Seckl JR, Flier JS. Transgenic amplification of glucocorticoid action in dipose tissue causes high blood pressure in mice. J Clin Invest 2003;112:83-90
35. Mikhail N, Golub MS, Tuck ML. Obesity and hypertension. Prog Cardivasc Dis 1999;42:39-58
36. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215
37. Ortiz MA, De Prado A, Donate T, Gallart L, Claramunt H, Hernandez M, Martinez J, Martinez E, Pou JM. Angiotensin-converting enzyme polymorphism gene and evolution of nephropathy to end-stage renal disease. Nephrology 2003;8:171-6
38. Panahloo A, Andres C, Mohamed-Ali V, Gould MM, Talmud P, Humphries SE. Yudkin JS. The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Circulation 1995;92:3390-3
39. Prasad A, Quyyumi AA. Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome. Circulation 2004;110:1507-12
40. Rigat B, Hubert C, Alhenc-Gelas A, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting-enzyme (ACE) gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6
41. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433
42. Ruiz J, Blanché H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91:3662-5
43. Scott J, Shoulders C, Navaratnam N, Aitman T. The genetics of the metabolic overlap syndrome. Proc Nutr Soc 2000;59:439
44. Shanmugan V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl 1993;3:120-1
45. Strazzullo P, Iacone R, Iacoviello L, Russo O, Barba G, Russo P, D'Orazio A, Barbato A, Cappuccio FP, Farinaro E, Siani A. Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study. Ann Intern Med 2003;138:17-23
46. Timar O, Sestier F, Levy E. Metabolic syndrome X: a review. Can J Cardiol 2000;16:779-89
47. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, Ishigami T, Yabana M, Kihara M, Inoue S, Ishii M. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 1997;10:629-33
48. Van Harmelen V, Ariapart P, Hoffstedt J, Lundkvist I, Bringman S, Arner P. Increased adipose angiotensinogen gene expression in human obesity. Obes Res 2000;8:337-41
49. Zhu X, Chang CYP, Yan D, Weder A, Cooper R, Luke A, Kan D, Chakravarti A. Associations between hypertension and genes in the renin-angiotensin system. Hypertension 2003;41:1027-34